Biotechnological production of 11α hydroxylated steroids using recombinant bacteria.

Summary of the technology

CSIC has developed a procedure for the biotechnological production of 11α hydroxylated
steroids by generating and subsequent use of recombinant bacteria. These recombinant
bacteria allow to perform microbial biotransformation processes that result in 11αhydroxylated steroid compounds from raw materials such as phytosterols and intermediate
products efficiently and economically. These compounds have numerous applications in
pharmacology.
Companies are sought for implementing and commercializing the new technology under
patent license agreement.
An offer for Patent Licensing

CSIC - Consejo Superior de Investigaciones Científicas

Biotransformation of Steroids


Bioreactor for steroids production Steroids are widely distributed in nature. Besides, for many years steroidal pharmaceuticals have been used to maintain quality of life when used as anti-tumor, antiinflammatory, antimicrobial, antiviral, anti-estrogenic and anti-allergic. Therefore, they have preventive and therapeutic activity in various pathologies Many of these compounds are chemically synthesized, however, in recent years, it is known that microbial transformation of steroids is highly effective in generating new steroidal drugs. It is important to remark that the hydroxylation of these compounds increases their biological activity when compared with non hydroxylated The Researchers have developed recombinant bacteria that can be used for direct production of steroid 11α-hydroxylated from natural steroids or synthons (intermediates in the industrial synthesis of steroid drugs) in a single fermentation process. Furthermore, these bacteria, unlike other microorganisms, do not produce side products in the process.

Main innovations and advantages


· Recombinat bacteria were generated from unusual strains in the biotechnological production of steroids · Obtaining steroids takes place in a single fermentation process without side products.
· The process can be applied to natural and non-hydroxylated steroids synthons.

Intellectual property status

  • Granted Patent
  • Patent application number :-

Related Keywords

  • Applications for Health
  • Pharmaceutics
  • Biological Sciences
  • Medicine, Human Health
  • Medical Research
  • Pharmaceutical Products / Drugs
  • Virus, Virology / Antibiotics / Bacteriology
  • Biology / Biotechnology
  • Industrial Biotechnology
  • Biobased Materials related to Industrial Biotechnology
  • Medical/health
  • Medical Health related
  • Therapeutic
  • Therapeutic services
  • Other therapeutic (including defibrillators)
  • Pharmaceuticals/fine chemicals
  • pharmacology
  • recombinant bacteria
  • steroids

About CSIC - Consejo Superior de Investigaciones Científicas

The Spanish National Research Council (in Spanish 'Consejo Superior de Investigaciones Científicas (CSIC)') is a government agency for basic and applied scientific research.

It is the largest public research organization in Spain, with presence in all the Autonomous Communities through 126 centers and 145 associated units.

CSIC - Consejo Superior de Investigaciones Científicas

Never miss an update from CSIC - Consejo Superior de Investigaciones Científicas

Create your free account to connect with CSIC - Consejo Superior de Investigaciones Científicas and thousands of other innovative organizations and professionals worldwide

CSIC - Consejo Superior de Investigaciones Científicas

Send a request for information
to CSIC - Consejo Superior de Investigaciones Científicas

About Technology Offers

Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.

Help

Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support